Pfizer Inc. today announced detailed results from the pivotal Phase 3 TALAPRO-3 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® ...
Stars Insider on MSN
Is an enlarged prostate dangerous?
Benign prostatic hyperplasia, also known as BPH, is a condition in which the prostate in men and those assigned male at birth ...
2don MSN
Scientists say we’re all farting more than we think with experts breaking down toilet habits by age
Farting. Trumping. Breaking wind. Dropping your hat. Taking a phone call from Mr. Brown. Whatever you call the process of ...
Discusses Challenges in Breast Cancer Drug Development and Innovation in Clinical Research May 19, 2026 4:00 PM ...
Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...
Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review ...
8don MSN
Harvard doctor invents ‘vagina on a chip’ to replace animal testing for women’s health issues
Harvard scientists have been honored for creating the world’s first “vagina-on-a-chip,” a groundbreaking device that mimics ...
Cuba: The Justice Department moved on Wednesday to unseal charges against Raúl Castro, the former president and defense ...
President Donald Trump underwent a physical examination. He reported everything checked out perfectly. This follows public ...
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced it will present new data across its oncology portfolio at the 2026 American Society of Clinical Oncology ...
16d
Celcuity Inc. Reports Release of First Quarter 2026 Financial Results and Provides Corporate Update
Phase 3 VIKTORIA-1 trial achieved primary endpoint with clinically meaningful improvement in progression-free survival in PIK3CA mutant cohort; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results